Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial II

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Osteoarthritis
Interventions
DRUG

TDS-943 (topical diclofenac sodium 4% spray)

DRUG

celecoxib

OTHER

placebo

Trial Locations (49)

11214

Brooklyn

16635

Duncansville

19020

Bensalem

21286

Towson

23455

Virginia Beach

28801

Asheville

29406

Charleston

30066

Marietta

30513

Blue Ridge

31406

Savannah

32168

New Smyrna Beach

33472

Boynton Beach

33484

Delray Beach

33702

St. Petersburg

34239

Sarasota

34761

Ococee

35209

Birmingham

35244

Birmingham

43302

Marion

44121

Cleveland

45246

Cincinnati

49009

Kalamazoo

53209

Milwaukee

60611

Chicago

64114

Kansas City

66202

Overland Park

68144

Omaha

72205

Little Rock

73103

Oklahoma City

73112

Oklahoma City

77627

Nederland

78209

San Antonio

78229

San Antonio

78704

Austin

80209

Denver

83702

Boise

85032

Phoenix

85225

Chandler

91361

Westlake Village

92610

Foothill Ranch

92618

Irvine

92801

Anaheim

92804

Anaheim

06810

Danbury

06460

Milford

06905

Stanford

02301

Brockton

08009

Berlin

08055

Medford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mika Pharma GmbH

INDUSTRY